Pharmacotherapeutics for
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is beginning practice in a large primary
care clinic. During orientation, the collaborating physician asks how the
APRN should approach prescribing medications to ensure safe, high-
quality patient care. Which action best reflects the professional
responsibilities of an APRN prescriber?
A. Prescribe medications primarily according to personal clinical
experience regardless of new evidence.
B. Integrate current evidence, patient preferences, clinical judgment,
and regulatory requirements into prescribing decisions.
C. Limit medication discussions to adverse effects because efficacy is
the physician's responsibility.
D. Delegate all medication counseling to nursing staff to improve clinic
efficiency.
Correct Answer: B
Rationale:
Evidence-based prescribing requires integrating the best available
evidence, patient values and preferences, clinical expertise, and
applicable state and federal regulations. APRNs are independently
accountable for safe prescribing, medication counseling, and
therapeutic monitoring. Option A ignores evidence-based practice.
Option C incorrectly minimizes the APRN's prescribing role. Option D is
inappropriate because counseling regarding medication risks, benefits,
and informed decision-making remains a core prescriber responsibility.
,Question 2
An AGPCNP evaluates a 72-year-old woman with newly diagnosed
hypertension. Before initiating pharmacotherapy, which additional
action is most appropriate to support safe prescribing?
A. Prescribe the medication with the lowest monthly cost.
B. Perform a comprehensive medication reconciliation, including
prescription drugs, over-the-counter medications, and herbal
supplements.
C. Delay treatment until specialty consultation is obtained.
D. Obtain genetic testing before selecting any antihypertensive
medication.
Correct Answer: B
Rationale:
Medication reconciliation helps identify duplicate therapy, drug
interactions, contraindications, and adherence concerns before
initiating treatment. Comprehensive review of all medications—
including supplements—is an essential component of safe prescribing.
Cost considerations are important but secondary to safety. Specialty
consultation is not routinely required, and pharmacogenomic testing is
not indicated for initial management of uncomplicated hypertension.
Question 3
An APRN is considering prescribing an opioid analgesic for acute
postoperative pain. Which prescribing action best demonstrates risk
reduction before issuing the prescription?
, A. Assume the patient has no history of controlled substance use
because none was volunteered.
B. Review the state's Prescription Drug Monitoring Program (PDMP)
when required or recommended before prescribing.
C. Prescribe the maximum allowable quantity to avoid refill requests.
D. Avoid discussing overdose risk because it may discourage adherence.
Correct Answer: B
Rationale:
Reviewing the PDMP is an important strategy for identifying potential
duplicate controlled substance prescriptions, multiple prescribers, and
misuse risk. Current U.S. prescribing practices encourage or require
PDMP review depending on jurisdiction. Option A may miss important
safety concerns. Option C increases unnecessary exposure to opioids.
Option D ignores an essential component of informed prescribing and
patient education.
Question 4
A patient asks why an APRN spends time discussing treatment options
rather than simply choosing the medication believed to be most
effective. Which response best explains patient-centered prescribing?
A. "Federal law requires patients to select their own medications."
B. "Shared decision-making improves adherence and helps align
treatment with your health goals and preferences."
C. "Medication selection is based primarily on patient preference
regardless of evidence."
Advanced Practice Nurse
Prescribers with Davis Edge
6th Edition
• Author(s)Teri Moser Woo; Wendy
L. Wright
TEST BANK
▪ The Foundation
▪ Pharmacotherapeutics with Single Drugs
▪ Pharmacotherapeutics with Multiple Drugs
▪ Special Drug Treatment Considerations
,Question 1
A family nurse practitioner (FNP) is beginning practice in a large primary
care clinic. During orientation, the collaborating physician asks how the
APRN should approach prescribing medications to ensure safe, high-
quality patient care. Which action best reflects the professional
responsibilities of an APRN prescriber?
A. Prescribe medications primarily according to personal clinical
experience regardless of new evidence.
B. Integrate current evidence, patient preferences, clinical judgment,
and regulatory requirements into prescribing decisions.
C. Limit medication discussions to adverse effects because efficacy is
the physician's responsibility.
D. Delegate all medication counseling to nursing staff to improve clinic
efficiency.
Correct Answer: B
Rationale:
Evidence-based prescribing requires integrating the best available
evidence, patient values and preferences, clinical expertise, and
applicable state and federal regulations. APRNs are independently
accountable for safe prescribing, medication counseling, and
therapeutic monitoring. Option A ignores evidence-based practice.
Option C incorrectly minimizes the APRN's prescribing role. Option D is
inappropriate because counseling regarding medication risks, benefits,
and informed decision-making remains a core prescriber responsibility.
,Question 2
An AGPCNP evaluates a 72-year-old woman with newly diagnosed
hypertension. Before initiating pharmacotherapy, which additional
action is most appropriate to support safe prescribing?
A. Prescribe the medication with the lowest monthly cost.
B. Perform a comprehensive medication reconciliation, including
prescription drugs, over-the-counter medications, and herbal
supplements.
C. Delay treatment until specialty consultation is obtained.
D. Obtain genetic testing before selecting any antihypertensive
medication.
Correct Answer: B
Rationale:
Medication reconciliation helps identify duplicate therapy, drug
interactions, contraindications, and adherence concerns before
initiating treatment. Comprehensive review of all medications—
including supplements—is an essential component of safe prescribing.
Cost considerations are important but secondary to safety. Specialty
consultation is not routinely required, and pharmacogenomic testing is
not indicated for initial management of uncomplicated hypertension.
Question 3
An APRN is considering prescribing an opioid analgesic for acute
postoperative pain. Which prescribing action best demonstrates risk
reduction before issuing the prescription?
, A. Assume the patient has no history of controlled substance use
because none was volunteered.
B. Review the state's Prescription Drug Monitoring Program (PDMP)
when required or recommended before prescribing.
C. Prescribe the maximum allowable quantity to avoid refill requests.
D. Avoid discussing overdose risk because it may discourage adherence.
Correct Answer: B
Rationale:
Reviewing the PDMP is an important strategy for identifying potential
duplicate controlled substance prescriptions, multiple prescribers, and
misuse risk. Current U.S. prescribing practices encourage or require
PDMP review depending on jurisdiction. Option A may miss important
safety concerns. Option C increases unnecessary exposure to opioids.
Option D ignores an essential component of informed prescribing and
patient education.
Question 4
A patient asks why an APRN spends time discussing treatment options
rather than simply choosing the medication believed to be most
effective. Which response best explains patient-centered prescribing?
A. "Federal law requires patients to select their own medications."
B. "Shared decision-making improves adherence and helps align
treatment with your health goals and preferences."
C. "Medication selection is based primarily on patient preference
regardless of evidence."
